The market leads globally due to its advanced biopharmaceutical industry, strong regulatory standards, and high demand for safe biologics and vaccine production. The market continues to grow with rising R&D investments, technological advancements in filtration systems, and increasing adoption across pharmaceutical, biotechnology, and research applications.
A viral removal filter system is a specialized filtration technology designed to remove or retain viruses from liquids or gases using membranes with very fine pores, typically on a size-exclusive principle. It is widely used in biopharmaceutical and healthcare processes to ensure the safety and purity of products such as biologics, vaccines, and blood-derived therapies by preventing contamination. The U.S. viral removal filter system market is growing due to its advanced biopharmaceutical industry, strong regulatory framework, and high demand for biologics and vaccines. Significant R&D investment, rapid adoption of innovative filtration technologies, and the presence of leading global companies further support the market expansion, making the U.S> a key hub for viral filtration advancements.
The global virus removal filter system market size was estimated at USD 4.18 billion in 2025 and is predicted to increase from USD 4.72 billion in 2026 to approximately USD 14.06 billion by 2035, expanding at a CAGR of 12.9% from 2026 to 2035.
The U.S. Viral removal filter systems market is expected to grow steadily due to increasing biologics production, rising adoption of single-use systems, and advancements in automated filtration technologies. Expanding cell and gene therapy pipelines and continuous innovation in bioprocessing are further strengthening future market potential.
| Metric | 2024 | 2025 |
| NIH Funding | 47.5 billion | 48.6 billion |
| FDA Biologics License Application Approvals | 18 | 22 |
| U.S. Pharmaceutical Manufacturing Value | 405 billion | 421 billion |
| U.S. R&D Expenditure | 230 billion | 242 billion |
The comparative data shows steady growth from 2024 to 2025, supported by increasing government funding, rising FDA approvals, and expanding pharmaceutical manufacturing output. Higher R&D investments and biologics production are directly boosting demand for viral removal filtration systems, reinforcing the U.S. market’s strong and consistent upward trajectory.
The consumables segment dominated the U.S. viral removal filter system market in 2025, with 68% share due to its continuous and repeated usage in biopharmaceutical manufacturing processes. Filter, membranes, and cartridges require frequent replacement to maintain sterility and performance. Increasing production of biologics and vaccines, along with strict regulatory standards, drives consistent demand, making consumables a major and recurring revenue-generating segment.
The ultrafiltration segment held a dominant share of 34% in the U.S. viral removal filter system market in 2025 due to its high efficiency in removing viruses while preserving critical biomolecules. Its scalability, cost-effectiveness, and compatibility with biopharmaceutical processes make it widely preferred. Strong regulatory acceptance and its ability to handle large volumes with consistent performance and its ability to handle large volumes with consistent performance further reinforced its leading position in the market.
The biopharmaceutical & biotechnology segment held a dominant share of 52% in the U.S. viral removal filter system market in 2025 due to increasing production of biologics, vaccines, and advanced therapies requiring strict viral safety. High R&D investments, expanding pipelines, and stringent regulatory standards drive strong demand for viral removal systems, making this segment the primary contributor to market growth.
The biopharmaceutical & biotechnology companies segment held a dominant share of 48% in the U.S. viral removal filter system market in 2025 due to their large-scale production of biologics, vaccines, and advanced therapies requiring strict viral safety. High R&D spending, continuous manufacturing activities, and stringent regulatory compliance needs drive consistent demand for viral removal filtration systems, securing their leading market position.
The polyethersulfone (PES) segment led the U.S. viral removal filter system market in 2025, with 36% share, due to its high flow rates, excellent chemical and thermal stability, and low protein binding characteristics. It ensures efficient viral removal while preserving product integrity, making it ideal for biopharmaceutical applications. Its durability, reliability, and strong regulatory acceptance further drive widespread adoption in the industry.
Leading companies in the market, including Merck KGaA, Danaher Corporation, Thermo Fisher Scientific, Sartorius AG, and Charles River Laboratories, dominate through advanced virus filtration systems, membranes, and bioprocessing technologies. These firms drive innovation in biologics, vaccines, and cell and gene therapies, while supporting strong market growth through continuous product development and expansion.
By Product Type
By Technology
By Application
By End User
By Membrane Material
